Related Experiment Videos
Myelodysplastic syndrome associated with hypotriploidy
1Department of Internal Medicine, Masuda Red Cross Hospital, Japan.
Acta Haematologica
|January 1, 1996
Summary
This case study details a rare instance of de novo myelodysplastic syndrome (MDS) with hypotriploidy, a severe chromosomal abnormality. The patient rapidly progressed to a more advanced stage, highlighting hypotriploidy as a poor prognostic indicator in MDS.
Area of Science:
- Hematology
- Cytogenetics
- Oncology
Background:
- Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
- Hypotriploidy, characterized by a near-haploid or hypotriploid chromosome number, is a rare cytogenetic abnormality in MDS.
Observation:
- A 64-year-old male presented with refractory anemia with ring sideroblasts (RARS).
- Bone marrow cytogenetic analysis revealed a complex hypotriploid karyotype: 65, X,-Y,+2,+6,-7,+8,-9,-10,+11,-12, add (12) (p11.2), +14,-16,-18,-19,20,-21,-21,+3mar[11/22]/46,XY[11/22].
- Despite initial hematological improvement with corticosteroids, anabolic steroids, and pyridoxine, the patient rapidly transformed to refractory anemia with excess of blasts in transformation.
Findings:
- The patient experienced rapid disease progression and transformation.
- The hypotriploid chromosomal abnormality was associated with a poor prognosis and rapid disease course.
- Death occurred due to multiple organ failure two months after RARS diagnosis.
Implications:
- This case underscores the significance of rare cytogenetic abnormalities like hypotriploidy in predicting MDS progression.
- Further research into the mechanisms and clinical impact of hypotriploidy in MDS is warranted.
- Understanding such rare karyotypes can aid in risk stratification and treatment strategies for MDS patients.